The short interest data are out for the most recent settlement date, January 13. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, with big potential upside and big potential downside. As we approached Trump’s inauguration, the health care sector in general rallied. Now it’s time to see what the bears have to say about this rally.
As we have said before, FDA rulings can make or break the biotech stocks, and short sellers and mega-bulls often go to war against each other in these companies. After all, if a single failed clinical trial can mean disaster for a stock, then some short sellers can argue for a stock implosion down the road.
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The January 13 short interest data have been compared with the previous report, and short interest was higher in most of the selected stocks.
Amgen Inc. (NASDAQ: AMGN) saw its short interest increase to 6.56 million shares from the previous level of 6.22 million. Shares were last seen trading at $154.14, in a 52-week trading range of $133.64 to $176.85.
Short interest in Biogen Inc. (NASDAQ: BIIB) increased to 2.25 million shares from the previous 2.07 million. The stock was recently trading at $273.24, within a 52-week range of $223.02 to $333.65.
Celgene Corp.’s (NASDAQ: CELG) short interest for this settlement date increased to 8.16 million shares from the previous 7.67 million. Shares were changing hands at $113.98, in a 52-week range of $93.05 to $127.00.
Gilead Sciences Inc. (NASDAQ: GILD) saw its short interest increase to 14.58 million shares from 13.37 million in the previous period. Shares were trading at $71.91, in a 52-week trading range of $69.78 to $103.10.
The number of MannKind Corp. (NASDAQ: MNKD) shares short decreased to 97.91 million. The previous reading was 98.60 million. The stock was last seen at $0.68, in a 52-week range of $0.41 to $2.24. Note that MannKind is one of the most shorted Nasdaq stocks.
Alexion Pharmaceuticals Inc.’s (NASDAQ: ALXN) short interest decreased to 5.44 million, compared to the previous level of 5.55 million. Shares were trading at $129.46, in a 52-week range of $109.12 to $162.00.
In addition, check out the most shorted Nasdaq stocks, which included Sirius XM, Intel and Yahoo.
Travel Cards Are Getting Too Good To Ignore (sponsored)
Credit card companies are pulling out all the stops, with the issuers are offering insane travel rewards and perks.
We’re talking huge sign-up bonuses, points on every purchase, and benefits like lounge access, travel credits, and free hotel nights. For travelers, these rewards can add up to thousands of dollars in flights, upgrades, and luxury experiences every year.
It’s like getting paid to travel — and it’s available to qualified borrowers who know where to look.
We’ve rounded up some of the best travel credit cards on the market. Click here to see the list. Don’t miss these offers — they won’t be this good forever.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.